Sign in
4

Changes in Ownership

Keros Therapeutics, Inc. Filed Acc 0001682068-26-000005

Options or other derivatives

  • CHIEF FINANCIAL OFFICER acquired 60,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Regnante Keith CHIEF FINANCIAL OFFICER 2026-02-24 Grant or award · Employee Stock Option (Right to Buy) +60,000 60,000 D: show line 1 in the form
Loading xslF345X05/form4-02262026_040214.xml…